Autotransfusion with cell saver for off-pump coronary artery bypass surgery: A randomized trial

Scandinavian Cardiovascular Journal

Volumn 40, Issue 3, 2006, Pages 194-198

  Damgaard, Sune ^a   Steinbrüchel, Daniel A ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CLOPIDOGREL; COUMARIN DERIVATIVE; HEMOGLOBIN; HEPARIN; NORADRENALIN; TRANEXAMIC ACID;

AGED; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL INSTRUMENT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 33748348846     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430600628292     Document Type: Article

References (8)

1. Murphy, GJ and Rogers, CS and Lansdowne, WB and Channon, I and Alwair, H and Cohen, A and (2005) Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: A randomized trial J Thorac Cardiovasc Surg., 130, pp. 20-8.
2. Bracey, AW and Radovancevic, R and Riggs, SA and Houston, S and Cozart, H and Vaughn, WK and (1999) Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome Transfusion., 39, pp. 1070-7.
3. Cheng, DC and Bainbridge, D and Martin, JE and Novick, RJ. (2005) Evidence-Based Perioperative Clinical Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials Anesthesiology., 102, pp. 188-203.
4. Kuduvalli, M and Oo, AY and Newall, N and Grayson, AD and Jackson, M and Desmond, MJ and (2005) Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery Eur J Cardiothorac Surg., 27, pp. 592-8.
5. Engoren, MC and Habib, RH and Zacharias, A and Schwann, TA and Riordan, CJ and Durham, SJ. (2002) Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg., 74, pp. 1180-6.
6. HenryDA, MoxeyAJ, CarlessPA, O'ConnellD, McClellandB, HendersonKM,. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 1999:CD001886.
7. CarlessPA, HenryDA, MoxeyAJ, O'ConnellDL, FergussonDA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2003:CD001888.
8. Chelemer, SB and Prato, BS and Cox, PM, Jr and O'Connor, GT and Morton, JR. (2002) Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery Ann Thorac Surg., 73, pp. 138-42.